These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 30964447)

  • 1. B lymphocytes protect islet β cells in diabetes prone NOD mice treated with imatinib.
    Wilson CS; Spaeth JM; Karp J; Stocks BT; Hoopes EM; Stein RW; Moore DJ
    JCI Insight; 2019 Apr; 5(9):. PubMed ID: 30964447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of residual beta cells and islet autoimmunity during increasing duration of diabetes in NOD mice and experimental approaches toward reversing new-onset disease with bioactive peptides.
    Reddy S; Cheung CC; Chai RC; Rodrigues JA
    Ann N Y Acad Sci; 2008 Dec; 1150():171-6. PubMed ID: 19120289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KLRG1 expression identifies short-lived Foxp3
    Kornete M; Mason E; Istomine R; Piccirillo CA
    Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2α-Methyl-19-nor-(20S)-1,25-dihydroxyvitamin D(3) protects the insulin 2 knockout non-obese diabetic mouse from developing type 1 diabetes without hypercalcaemia.
    Kiekhaefer CM; Weber B; Huggins M; Gorichanaz C; Nehring JA; DeLuca HF
    Clin Exp Immunol; 2011 Dec; 166(3):325-32. PubMed ID: 22059989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cells and type 1 diabetes ...in mice and men.
    Hinman RM; Smith MJ; Cambier JC
    Immunol Lett; 2014 Aug; 160(2):128-32. PubMed ID: 24472603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAHSAs attenuate immune responses and promote β cell survival in autoimmune diabetic mice.
    Syed I; Rubin de Celis MF; Mohan JF; Moraes-Vieira PM; Vijayakumar A; Nelson AT; Siegel D; Saghatelian A; Mathis D; Kahn BB
    J Clin Invest; 2019 Aug; 129(9):3717-3731. PubMed ID: 31380811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic duodenal homeobox 1 protein is a novel beta-cell-specific autoantigen for type I diabetes.
    Li SW; Koya V; Li Y; Donelan W; Lin P; Reeves WH; Yang LJ
    Lab Invest; 2010 Jan; 90(1):31-9. PubMed ID: 19901909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inotuzumab ozogamicin murine analog-mediated B-cell depletion reduces anti-islet allo- and autoimmune responses.
    Carvello M; Petrelli A; Vergani A; Lee KM; Tezza S; Chin M; Orsenigo E; Staudacher C; Secchi A; Dunussi-Joannopoulos K; Sayegh MH; Markmann JF; Fiorina P
    Diabetes; 2012 Jan; 61(1):155-65. PubMed ID: 22076927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo islet protection by a nuclear import inhibitor in a mouse model of type 1 diabetes.
    Moore DJ; Zienkiewicz J; Kendall PL; Liu D; Liu X; Veach RA; Collins RD; Hawiger J
    PLoS One; 2010 Oct; 5(10):e13235. PubMed ID: 20949090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
    Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
    J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
    Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
    J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib prevents beta cell death in vitro but does not improve islet transplantation outcome.
    King AJ; Griffiths LA; Persaud SJ; Jones PM; Howell SL; Welsh N
    Ups J Med Sci; 2016 May; 121(2):140-5. PubMed ID: 26953716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of type 1 diabetes in NOD mice knockout for the osteopontin gene.
    Melanitou E
    Gene; 2020 Aug; 753():144785. PubMed ID: 32445922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
    Redd S; Ginn S; Ross JM
    Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-cell-specific IL-35 therapy suppresses ongoing autoimmune diabetes in NOD mice.
    Manzoor F; Johnson MC; Li C; Samulski RJ; Wang B; Tisch R
    Eur J Immunol; 2017 Jan; 47(1):144-154. PubMed ID: 27859048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
    Jalili RB; Zhang Y; Hosseini-Tabatabaei A; Kilani RT; Khosravi Maharlooei M; Li Y; Salimi Elizei S; Warnock GL; Ghahary A
    PLoS One; 2016; 11(1):e0146970. PubMed ID: 26765526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes.
    Nigi L; Brusco N; Grieco GE; Licata G; Krogvold L; Marselli L; Gysemans C; Overbergh L; Marchetti P; Mathieu C; Dahl Jørgensen K; Sebastiani G; Dotta F
    Front Endocrinol (Lausanne); 2020; 11():630. PubMed ID: 33042009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B lymphocyte "original sin" in the bone marrow enhances islet autoreactivity in type 1 diabetes-prone nonobese diabetic mice.
    Henry-Bonami RA; Williams JM; Rachakonda AB; Karamali M; Kendall PL; Thomas JW
    J Immunol; 2013 Jun; 190(12):5992-6003. PubMed ID: 23677466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal islet sphingolipid metabolism in type 1 diabetes.
    Holm LJ; Krogvold L; Hasselby JP; Kaur S; Claessens LA; Russell MA; Mathews CE; Hanssen KF; Morgan NG; Koeleman BPC; Roep BO; Gerling IC; Pociot F; Dahl-Jørgensen K; Buschard K
    Diabetologia; 2018 Jul; 61(7):1650-1661. PubMed ID: 29671030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-2 immunotherapy reveals potential for innate beta cell regeneration in the non-obese diabetic mouse model of autoimmune diabetes.
    Diaz-de-Durana Y; Lau J; Knee D; Filippi C; Londei M; McNamara P; Nasoff M; DiDonato M; Glynne R; Herman AE
    PLoS One; 2013; 8(10):e78483. PubMed ID: 24205242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.